Subsequently, we explored the relationship of each composite score with Alzheimer’s disease pathology (p-tau/Aβ42), synaptic dysfunction (SNAP-25), neurodegeneration (NFL) and cognition (MMSE) in linear regression models adjusting for age, sex and diagnosis (Table 2). This evidence concerns the gene MAPT and Alzheimer disease.